AI Engines For more Details: Perplexity Kagi Labs You
Allergic Rhinitis: Carbinoxamine maleate helps relieve symptoms associated with allergic rhinitis, including sneezing, runny or stuffy nose, itching, and nasal congestion. It blocks the action of histamine, a chemical released during allergic reactions that causes inflammation and symptoms.
Allergic Conjunctivitis: Carbinoxamine maleate may be used to alleviate symptoms of allergic conjunctivitis, such as redness, itching, and watery eyes. It helps reduce inflammation and irritation in the eyes caused by allergic reactions.
Urticaria (Hives): Carbinoxamine maleate can be effective in treating acute episodes of hives (urticaria) by reducing itching and skin rash associated with allergic reactions.
Pruritus (Itching): It may also be prescribed for the symptomatic relief of itching associated with allergic skin conditions, such as atopic dermatitis (eczema) or contact dermatitis.
Motion Sickness: Carbinoxamine maleate has anticholinergic properties, which can help alleviate symptoms of motion sickness, including nausea and vomiting. It is sometimes used in combination with other medications for motion sickness relief.
Common Cold: Carbinoxamine maleate may be included in some over-the-counter cough and cold medications to relieve symptoms such as sneezing, runny nose, and nasal congestion. However, its efficacy for this purpose is limited, and it is not recommended for children under certain ages due to safety concerns.
Antiemetic: In addition to its antihistamine properties, carbinoxamine maleate has mild antiemetic (anti-nausea) effects, which may be beneficial for individuals experiencing nausea or vomiting due to motion sickness or other causes.
Side Effects: Common side effects of carbinoxamine maleate may include drowsiness, dizziness, dry mouth, blurred vision, constipation, and urinary retention. These side effects are more common with higher doses and may be more pronounced in elderly individuals.
Sedative Effects: Carbinoxamine maleate can cause sedation and impair cognitive and motor function, especially when taken in higher doses or in combination with other medications that have sedative effects. Patients should avoid activities requiring mental alertness, such as driving or operating machinery, until they know how the medication affects them.
Caution: Carbinoxamine maleate should be used with caution in certain populations, including elderly individuals, children, pregnant women, and individuals with certain medical conditions (such as glaucoma, urinary retention, or prostate enlargement). It is important to consult a healthcare professional before using carbinoxamine maleate, especially in these populations.
| Rank | Probiotic | Impact |
|---|---|---|
| species | Lacticaseibacillus paracasei | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| ADHD | 0 | 0 | |
| Allergies | 0.1 | -0.1 | |
| Alzheimer's disease | 0 | 0.6 | 0 |
| Ankylosing spondylitis | 0.1 | 0 | 0 |
| Atherosclerosis | 0 | 0 | |
| Atrial fibrillation | 0.1 | -0.1 | |
| Autism | 0.9 | 0.2 | 3.5 |
| Barrett esophagus cancer | 0 | 0 | |
| Biofilm | 0 | 0 | |
| Cancer (General) | 0.1 | -0.1 | |
| Celiac Disease | 0.1 | 0.1 | |
| Chronic Fatigue Syndrome | 0.2 | 0.1 | 1 |
| Chronic Kidney Disease | 0.6 | 0.6 | |
| Chronic Obstructive Pulmonary Disease (COPD) | 0 | 0 | |
| Chronic Urticaria (Hives) | 0.1 | -0.1 | |
| Colorectal Cancer | 0 | 0 | |
| Constipation | 0.1 | 0.1 | |
| COVID-19 | 0.3 | 0.5 | -0.67 |
| Crohn's Disease | 0 | 0 | 0 |
| Depression | 0.5 | 0.1 | 4 |
| Eosinophilic Esophagitis | 0 | 0 | |
| Epilepsy | 0 | 0 | |
| Fibromyalgia | 0.3 | 0.1 | 2 |
| Functional constipation / chronic idiopathic constipation | 0.1 | 0.7 | -6 |
| gallstone disease (gsd) | 0 | 0 | |
| Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.2 | 0.2 | |
| Generalized anxiety disorder | 0 | 0 | |
| Halitosis | 0 | 0 | |
| Hashimoto's thyroiditis | 0.6 | 0.6 | |
| Hidradenitis Suppurativa | 0 | 0 | |
| IgA nephropathy (IgAN) | 0.1 | -0.1 | |
| Inflammatory Bowel Disease | 0.3 | 0.1 | 2 |
| Intelligence | 0.1 | -0.1 | |
| Irritable Bowel Syndrome | 0.1 | -0.1 | |
| Liver Cirrhosis | 0 | 0 | |
| Long COVID | 0.4 | 0 | 0 |
| ME/CFS with IBS | 0 | 0 | |
| ME/CFS without IBS | 0.1 | 0.1 | |
| Metabolic Syndrome | 0 | 0.2 | 0 |
| Mood Disorders | 0.5 | 0.1 | 4 |
| Multiple Sclerosis | 0 | 0.1 | 0 |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.1 | 0.1 | |
| Obesity | 0.6 | 0.2 | 2 |
| obsessive-compulsive disorder | 0.1 | 0.7 | -6 |
| Osteoarthritis | 0.3 | 0.3 | |
| Parkinson's Disease | 0.2 | 0.3 | -0.5 |
| Polycystic ovary syndrome | 0.1 | 0.1 | |
| Psoriasis | 0.1 | -0.1 | |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 0.1 | 0 | 0 |
| Rosacea | 0.6 | 0.6 | |
| Sjögren syndrome | 0.1 | 0.1 | |
| Sleep Apnea | 0 | 0 | |
| Small Intestinal Bacterial Overgrowth (SIBO) | 0 | 0 | |
| Stress / posttraumatic stress disorder | 0 | 0 | |
| Systemic Lupus Erythematosus | 0 | 0 | |
| Tic Disorder | 0.1 | 0.1 | 0 |
| Type 1 Diabetes | 0.1 | 0.1 | 0 |
| Type 2 Diabetes | 0.2 | 0.2 | 0 |
| Ulcerative colitis | 0.1 | 0.2 | -1 |
| Unhealthy Ageing | 0.8 | 0.8 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations / Info / Descriptions are influenced by < a href = "/home/sources" target = "_blank" > Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2024 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription
All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions / Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [44.222.131 ]
Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [44.222.131 ]
